Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko acquired 50,811 shares of the stock in a transaction dated Wednesday, December 6th. The shares were bought at an average cost of $0.84 per share, for a total transaction of $42,681.24. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Repro-Med Systems, Inc. (OTCMKTS REPR) traded up $0.01 on Thursday, reaching $0.86. The company’s stock had a trading volume of 22,700 shares, compared to its average volume of 57,122. The firm has a market cap of $32.24, a price-to-earnings ratio of 85.00 and a beta of -0.36. Repro-Med Systems, Inc. has a 12-month low of $0.34 and a 12-month high of $0.86.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/07/insider-buying-repro-med-systems-inc-repr-director-buys-50811-shares-of-stock.html.

About Repro-Med Systems

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

Insider Buying and Selling by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Receive News & Ratings for Repro-Med Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.